top of page

Health & Pharmaceutical

OUR EXPERTISE

Mahendra & Co. specializes in providing comprehensive legal services to clients in the health industry. Our team of experienced attorneys is well-versed in the legal requirements governing healthcare, pharmaceuticals, and medical law. We are dedicated to offering the best legal advice to help our clients navigate the complex and evolving regulatory landscape of the health sector.

Our health law services include:
- Advising on medical law, including patient rights, healthcare provider obligations, and medical malpractice
- Assisting with the application and renewal of health and pharmaceutical licenses
- Drafting and reviewing pharmaceutical and healthcare agreements, including distribution and supply contracts
- Ensuring compliance with regulatory standards, including food and drug safety regulations
- Providing legal guidance on the establishment and operation of healthcare facilities, such as hospitals and clinics
- Representing clients in disputes related to healthcare practices, medical negligence, and regulatory violations
- Offering strategic legal counsel on mergers, acquisitions, and joint ventures within the healthcare and pharmaceutical sectors

With our deep understanding of healthcare regulations and industry-specific legal challenges, we are committed to supporting our clients in maintaining compliance and achieving their business goals in the health industry.

Contact us to discuss how we can provide legal solutions tailored to your healthcare or pharmaceutical needs.

Read more about our Clients & Projects to learn what we served.

LATEST INSIGHTS

12 June 2025

Licensing Reform in Effect: What Every Business Actor Should Know About PP 28/2025 and Its Centralized Approach

Licensing Reform in Effect: What Every Business Actor Should Know About PP 28/2025 and Its Centralized Approach

PP 28/2025 officially revokes PP 5/2021 as of 5 June 2025 and introduces a more centralized risk-based business licensing system. While it still adopts a risk-based approach, the new regulation emphasizes the centralization of authority, adjustments to the OSS system, and detailed transitional provisions for licenses currently in process or already issued. Business actors are advised to closely observe the transitional provisions and update their OSS access data to ensure the continuity and legality of their operations.

Licensing Reform in Effect: What Every Business Actor Should Know About PP 28/2025 and Its Centralized Approach

12 June 2025

PP 28/2025 officially revokes PP 5/2021 as of 5 June 2025 and introduces a more centralized risk-based business licensing system. While it still adopts a risk-based approach, the new regulation emphasizes the centralization of authority, adjustments to the OSS system, and detailed transitional provisions for licenses currently in process or already issued. Business actors are advised to closely observe the transitional provisions and update their OSS access data to ensure the continuity and legality of their operations.

Pemerintah Resmi Cabut Perizinan Berbasis Risiko PP 5/2021: PP 28/2025 Berlaku Efektif Sejak 5 Juni 2025

12 June 2025

PP 28/2025 resmi mencabut PP 5/2021 sejak 5 Juni 2025 dan memperkenalkan sistem perizinan berusaha berbasis risiko yang lebih terpusat. Meskipun tetap mengadopsi pendekatan berbasis risiko, peraturan ini menekankan sentralisasi kewenangan, penyesuaian OSS, serta pengaturan transisi yang ketat bagi perizinan yang sedang atau telah diproses. Pelaku usaha wajib mencermati ketentuan peralihan dan melakukan pemutakhiran hak akses OSS guna memastikan kelangsungan legalitas kegiatan usaha.

Mahendra & Co. Law Firm Official Statement

16 May 2025

Mahendra & Co. Law Firm reminds Clients to use only our official contact information. Unofficial channels are not affiliated with us and may pose security risks. Please read this article for further assurance and detailed information.
bottom of page